SyntheMed Announces New Management Ap...(o obtain and maintain required regulator...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
SyntheMed Announces New Management Appointments
Date:10/2/2008
o obtain and maintain required regulatory approvals; (ii) potential inability to secure funding as and when needed to support the company's future activities and (iii) unanticipated delays associated with manufacturing and marketing activities. Reference is made to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007 for a description of these, as well as other, risks and uncertainties.
'/>"/>
| SOURCE SyntheMed, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. SyntheMed Completes $4.0 Million Equity Placement
2. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
3. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
4. SyntheMed Files Universal Shelf Registration
5. SyntheMed to Present at the Acumen BioFin Conference
6. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
7. Alba Therapeutics Corporation Announces Promotions
8. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
9. 23andMe Announces Breast Cancer Initiative
10. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
11. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results
Post Your Comments:
Breaking Biology Technology:Oxford BioTherapeutics Appoints Michael Moore as Chairman 2Oxford BioTherapeutics Appoints Michael Moore as Chairman 3Oxford BioTherapeutics Appoints Michael Moore as Chairman 4Dendreon Announces Proposed Public Offering of Common Stock 2Dendreon Announces Proposed Public Offering of Common Stock 3Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property 2PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision 2
[0] Oxford BioTherapeutics Appoints Michael Moore as Chairman[0] Dendreon Announces Proposed Public Offering of Common Stock[0] Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property[0] PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
Other Biology Technology:Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results 2Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results 3Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results 4Osteotech's Plexur M(TM) Biocomposite Receives FDA Clearance in Spine 2
Breaking Biology News(10 mins):Abundance of a look-alike species clouds population status of a million dollar fish 2Abundance of a look-alike species clouds population status of a million dollar fish 3Old hay and Alpine ibex horns reveal how grasslands respond to climate change 2Old hay and Alpine ibex horns reveal how grasslands respond to climate change 3UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students 2Texas Health Hospitals to Receive Financial Awards for Quality 54624 1Texas Health Hospitals to Receive Financial Awards for Quality 54624 2Texas Health Hospitals to Receive Financial Awards for Quality 54624 3Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors 13592 1Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors 13592 2Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors 13591 1Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors 13591 2Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors 13591 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |